Get the SPI Wire

FIBROBIOLOGICS, INC.

NASDAQ:FBLG
Annual Meeting

of Shareholders

MEETING DATE

09/17/2026
DEF 14A FILED
07/31/2026
PUBLISHED
07/31/2026 1:14 pm
TIME TO PUBLISH
08/02/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:FBLG · CUSIP 31573L105 · CLASS common stock and Series C Preferred Stock · CIK 0001958777

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

1
FOR
0
AGAINST
0
WITHHOLD
1
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
Approval, for purposes of Nasdaq Listing Rule 5635(d), of the issuance of up to 8,163,266 shares of common stock pursuant to the SPA and up to 285,714 shares of common stock pursuant to the Engagement Letter in connection with the SPA
other
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Failure to approve may require liquidated damages payments under the Warrants and Placement Agent Warrants.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

f4682e1d03ec3038e3f352c92e5ae9aaebbf9cb9c63a6da76547c909a1e73b47

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates